EUVIMEDEUVIMED entdecken
Crossref

Association of estrogen and progesterone receptor status and metabolic hormones with tumor progression in endometrial cancer

I. H. Ali, S. M. Hasan, N. H. Khedhir, O. Mohsein

The Ukrainian Biochemical Journal · 15.06.2026 · 98 (3) · 112-121

DOI: 10.15407/ubj98.03.112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 15.06.2026. Verfasst von I. H. Ali und 3 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is recognized that endometrial physiology and carcinogenesis depend on the balan­ce of estrogen and progesterone. Eхpression status of estrogen (ER) and progesterone (PR) receptors has been utilized clinically as a prognostic predictor of endometrial cancer (EC). Nevertheless there is growing evidence that insulin resistance and changes in adipokine secretory system are also important risk factor of EC.

Objective

To investigate the association between tumor estrogen and progesterone receptors expression combined with metabolic hormone serum levels and tumor progression in patients with endometrial cancer.

Methods

The study included 100 patients with endometrial cancer patients and 50 age-matched healthy controls. Serum estradiol, progesterone, insulin, leptin and adiponectin were analyzed with a chemiluminescent immunoassay. Tumor tissue samples were stained using monoclonal antibodies against ER and PR with a standard streptavidin-biotin method. Nuclear staining ≥10% was considered positive.

Results

It was shown that the majority of the tumors were ER-positive (68%) and PR-positive (54%) while 27% were double-nega­tive. Serum estradiol, leptin, and insulin levels were significantly higher in advanced-stage patients, while progesterone and adiponectin levels were significantly lower compared to early-stage patients. Correlation and regression results showed that the independent variables that predicted tumor progression were ER and PR negativity, high estradiol, high leptin, and low adiponectin.

Conclusions

The loss of ER/PR expression and a metabolic hormonal imbalance – characterized by elevated levels of estradiol and leptin and reduced levels of adiponectin – are closely associated with the progression of endometrial cancer. These changes may contribute to proliferative signaling pathways and inflammatory processes, leading to increased tumor aggressiveness and disease progression. Keywords: adiponectin, endometrial cancer, estrogen receptor, insulin, leptin, monoclonal antibodies, progesterone receptor

Zitieren

APA

Ali, I. H., Hasan, S. M., Khedhir, N. H., & Mohsein, O. (2026). Association of estrogen and progesterone receptor status and metabolic hormones with tumor progression in endometrial cancer. The Ukrainian Biochemical Journal, 98(3), 112-121. https://doi.org/10.15407/ubj98.03.112

Vancouver

Ali IH, Hasan SM, Khedhir NH, Mohsein O. Association of estrogen and progesterone receptor status and metabolic hormones with tumor progression in endometrial cancer. The Ukrainian Biochemical Journal. 2026;98(3):112-121. doi:10.15407/ubj98.03.112

BibTeX
@article{Ali2026,
  author = {Ali, I. H. and Hasan, S. M. and Khedhir, N. H. and Mohsein, O.},
  title = {Association of estrogen and progesterone receptor status and metabolic hormones with tumor progression in endometrial cancer},
  journal = {The Ukrainian Biochemical Journal},
  year = {2026},
  volume = {98},
  number = {3},
  pages = {112--121},
  doi = {10.15407/ubj98.03.112}
}
Kostenlos starten →